“In-vitro characterisation of a novel antimicrobial agent, TNP-2092, against Helicobacter pylori clinical isolates”, Swiss Med Wkly, vol. 148, no. 2930, p. w14630, Jul. 2018, doi: 10.4414/smw.2018.14630.